Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$0.31 - $0.57 $8,708 - $16,013
28,093 New
28,093 $13,000
Q2 2022

Aug 15, 2022

SELL
$0.94 - $1.76 $6,569 - $12,300
-6,989 Reduced 27.05%
18,846 $23,000
Q1 2022

May 13, 2022

BUY
$1.42 - $2.09 $7,314 - $10,765
5,151 Added 24.9%
25,835 $38,000
Q4 2021

Feb 11, 2022

SELL
$1.42 - $2.13 $14,346 - $21,519
-10,103 Reduced 32.82%
20,684 $41,000
Q3 2021

Nov 12, 2021

BUY
$1.42 - $2.0 $23,694 - $33,372
16,686 Added 118.33%
30,787 $51,000
Q2 2021

Aug 12, 2021

BUY
$1.21 - $1.89 $17,062 - $26,650
14,101 New
14,101 $27,000

Others Institutions Holding DARE

About Dare Bioscience, Inc.


  • Ticker DARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,820,896
  • Market Cap $270M
  • Description
  • Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...
More about DARE
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.